| 1 |
How might using gold nanoparticles in electrochemical sensors enhance early-stage disease detection?
|
2. By increasing surface interactions for more accurate biomarker capture |
|
Increased surface area enhances electron transfer rates |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following best explains how label-free electrochemical sensors support point-of-care medical diagnostics?
|
3. They provide direct measurement of target molecules with minimal preparation |
|
They require minimal step |
Electrochemical biosensors can be categorized based on the type of recognition element and the detection strategy used. Label-free detection is more straightforward and avoids the need for additional reagents or steps, whereas labeled methods often require the use of secondary antibodies or enzymatic tags that can complicate the assay and increase the cost and time required. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why is electrochemical transduction considered advantageous over optical transduction in medical diagnostic sensors?
|
3. It eliminates the need for a signal output system |
|
|
Chemical sensors use synthetic recognition elements such as molecularly imprinted polymers (MIPs) or ionophores to detect specific chemical species. These sensors are often used for detecting environmental pollutants or toxins. Gas sensors are designed to detect gaseous analytes typically rely on materials like metal oxides that change their electrical resistance upon exposure to gases such as carbon monoxide, ammonia, or volatile organic compounds. Immunosensors utilize antibodies as the recognition element to specifically bind to antigens providing high specificity for detecting pathogens or biomarkers in medical diagnostics. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which action would most effectively increase specificity in a sensor designed to detect a single disease biomarker?
|
3. Functionalizing the electrode with disease-specific aptamers |
|
ตั้งค่าการทำงานของอิเล็กโทรดให้ตรวจจับแค่บางโรคเป็นวิธีที่ดีในการใช้าน |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
In a scenario where a sensor must detect ultra-low concentrations of a cancer biomarker, which modification is most critical?
|
4. Using a paper-based strip sensor |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why might two electrochemical sensors using the same nanomaterial produce inconsistent results?
|
3. Variations in nanomaterial synthesis affect structural uniformity |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which characteristic makes nanotechnology-based electrochemical sensors especially suitable for wearable medical devices?
|
3. They allow miniaturization without losing sensitivity |
|
เหมาะกับการใส่ทางการแพทย์มากเพราะมีขนาดเล็กและตรวจจับได้แม่นยำ |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What would likely happen if the bioreceptor layer is poorly immobilized on the sensor surface?
|
3. Target biomolecules may not bind effectively, leading to weak or inaccurate signals |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Which modification would most directly enhance electron transfer in the sensor system?
|
3. Decreasing electrode surface roughness |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
How can digital sensing technologies best support personalized cancer care?
|
2. By collecting real-time data on patient-specific symptoms and responses |
|
การที่ระบบจะ analyze ข้อมูลได้ต้องมีการเก็บข้อมูลแบบเรียลไทม์ |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
If a clinician needs to monitor fatigue and motion in cancer patients at home, which device should be prioritized?
|
1. Digital ELISA chips |
|
การที่ผู้ป่วยอยู่บ้านไม่ต้องไปไหนมาไหนจึงต้องการหลักๆแค่ตัวชิป |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Why is combining sensor data with patient-reported outcomes (PROs) important in digital cancer care?
|
3. It allows a holistic understanding of patient experience |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
A hospital invested in wearable digital monitoring but received low engagement from patients. Which of the following is most likely a contributing factor?
|
5. Use of invasive surgical methods |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which future trend is most aligned with the development of emerging digital cancer platforms?
|
2. Creation of pocket-sized biosensing tools integrated with smartphones |
|
ในอนาคตอาจมีแนวโน้มสร้างสิ่งที่สะดวกและเกิดผลกระทบน้อยที่สุดในการตรวจหาและรักษาโรคมะเร็ง |
The future of digital sensor platforms for cancer diagnosis has gained significance through innovative technologies that enhance detection methods' sensitivity, speed, and personalization. These future trends and potential breakthroughs could revolutionize early cancer detection and patient care |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How can real-time symptom monitoring positively affect treatment decisions?
|
3. By enabling rapid intervention before major deterioration |
|
หากเกิดอะไรขึ้นการแทรคแบบเรียลไทม์จะได้รู้ทันที |
Real-time monitoring involves the continuous or near-continuous measurement of physiological parameters, providing immediate feedback and enabling proactive medical interventions. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Which technology is best suited to detect rare cancer biomarkers with high precision?
|
1. Digital ELISA |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
Why is collaboration between data scientists and clinicians essential in digital oncology platforms?
|
3. Data insights require clinical validation for real-world use |
|
การร่วมมือกันระหว่างนักวิทยศาสตร์และแพทย์จะเป็นผลดีกว่า เพราะนักวิทยาศาสตร์สามารถดูแลเครื่องมือได้ในขณะที่แพทย์มีความรู้ความเข้าใจเกี่ยวกับโรคการรักษาอย่างชัดเจน |
As digital biosensor technologies progress toward clinical adoption, robust validation through clinical trials is essential to establish their diagnostic reliability and regulatory approval. To ensure safety, efficacy, and reliability, rigorous clinical trials and validation studies are essential as these technologies transition from lab-based research to practical healthcare applications |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
Which outcome is most likely when cancer patients actively use digital health tools to track their condition?
|
2. They engage more actively in shared treatment decisions |
|
|
Prompt and accurate diagnostics improve patient outcomes by facilitating timely treatment and reducing the risk of complications. Wearable real-time monitoring devices are convenient and non-invasive, improving patient compliance with monitoring regimens. The integration of nanotechnology into electrochemical sensors has revolutionized their rapid response and real-time monitoring capabilities. These advancements are pivotal in enhancing the efficiency and effectiveness of medical diagnostics, ultimately leading to better patient care and health outcomes |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
A research team is developing a highly selective electrochemical sensor for detecting cancer biomarkers in blood. Based on the diagram, which combination of nanoparticle properties would most likely enhance both specificity and signal sensitivity?
|
1. Large rod-shaped particles with neutral surface charge |
|
เกี่ยวกับการตอบสนองของพื้นที่ |
The high surface area to volume ratio of nanomaterials enhances their reactivity and interaction with other substances. At the nanoscale, quantum effects can alter optical, electrical, and magnetic properties, enabling novel functionalities. Nanomaterials often exhibit superior strength, flexibility, and durability compared to their bulk counterparts. Nanotechnology is a transformative field with the potential to revolutionize numerous industries through the development of materials and devices with unique properties and functionalities. In medical diagnostics, the integration of nanotechnology with electrochemical sensors has opened up new possibilities for highly sensitive, specific, and rapid detection of various biomarkers and pathogens [45,46]. As research and development in this field continue to advance, the scope of nanotechnology's impact is expected to expand, driving innovation and improving quality of life. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
A hospital is planning to adopt a single digital sensing platform to support a wide range of diagnostic applications. Based on the image, which of the following most justifies this decision?
|
2. One platform can be customized to detect toxins, cancer biomarkers, and heavy metals using interchangeable biorecognition elements |
|
Digital sensing platforms can be use in many ways |
LOC technologies have emerged as a transformative approach in digital diagnostics by miniaturizing and integrating laboratory processes onto a single micro-device, significantly advancing point-of-care cancer detection (Fig. 4). LOC technology integrates multiple laboratory functions with a miniaturized chip for performing a wide range of laboratory techniques such as sample preparation, separation, and detection. Compared to the traditional methods, LOC devices offer several key advantages: they are compact, portable, require minimal sample volumes, and provide real-time responses. In biosensing applications, LOC technologies enable POC testing and on-site diagnostics. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|